Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
When To Apply Zero Based Budgeting Strategies
Timing matters with Zero Based Budgeting. This guide highlights scenarios and cues to start applying strategies for best impact in changing finances.
20,192 articles
Palantir-Moder Partnership Targets Mortgage Ops with AI
Palantir Technologies and Moder unveil a joint AI powered mortgage operations platform, piloted by Freedom Mortgage, ...
Can $100 Conflict Iran Have Any Real Market Impact on Stocks?
Oil rose past $100 per barrel as tensions involving Iran added a geopolitical layer to markets. Yet the S&P 500 showe...
These Cryptocurrencies More 2026: Are Any Worth Buying?
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
Director Trim Andersons, with Stock in Play: Insights for Investors
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...
Could Buying Oklo Stock Be the Breakthrough Investment?
Could buying oklo stock spark a life-changing return, or is it a high-stakes gamble? This guide breaks down what the ...
Lucd 2026 Earnings Transcript: Key Takeaways for Investors
A fresh take on LUCD's early 2026 results, this analysis dives into the lucd 2026 earnings transcript to unpack reven...
Why Professional Fund Managers Lose to the S&P 500
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
Should Nike Stock? A Practical Guide to Buying the Dip
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
OpenAI Going Public Wrong? Key Risks Investors Face
As whispers of an OpenAI IPO grow louder, investors must ask: is openai going public wrong for reasons that could der...
This Tech Stock Down: A Gift Investors Often Miss Today
When a major tech name drops, many investors feel the urge to retreat. Yet history shows that this tech stock down mo...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status